News
A series of panels convened by the Food and Drug Administration is raising concerns that the agency is skirting federal rules ...
A highly anticipated White House report on the health of American children would stop short of proposing direct restrictions ...
9don MSN
How a one-minute jolt from the SetPoint implant offers new hope for autoimmune disease patients
The US Food and Drug Administration has approved a new medical device for rheumatoid arthritis. The SetPoint System is an ...
Bayer & Kumquat Biosciences enter global license and collaboration to develop and commercialize Kumquat’s KRAS G12D inhibitor: Berlin, Germany Wednesday, August 13, 2025, 11:00 ...
Bayer and Kumquat Biosciences Enter Global Exclusive License and Collaboration in Precision Oncology
Bayer and Kumquat Biosciences Inc., a clinical-stage biotech company founded by pioneers of the KRAS pathway, today announced that they have entered into an exclusive global license and collaboration ...
PureTech Health plc PureTech Announces the Launch of Celea Therapeutics with a Mission to Transform the Treatment of Respiratory Diseases Former Teva North America CEO Sven Dethlefs, PhD, to lead ...
Conservatives, anti-abortion groups and members of the “Make America Healthy Again” movement have pushed for a method known as “restorative reproductive medicine” instead.
The Food and Drug Administration raised the risk of two recalled products from Sugar-free sweetener company NuNaturals.
MAXONA Pharmaceuticals is Developing MAX-001 as a Non-Opioid, Non-NSAID Oral Therapy for the Treatment of Acute and Chronic Pain IND Submission Marks Fourth Significant Development Milestone for ...
A former head of the Food and Drug Administration who led the charge against tobacco companies in the 1990s is aligning himself with Health Secretary Robert F. Kennedy Jr.’s war on ...
A pair of new papers unlock crucial new insights into what goes on in the body when anaphylaxis occurs, and indicate how an existing asthma medication could one day help prevent these life ...
DALLAS-- (BUSINESS WIRE)-- Starlight Therapeutics, a wholly owned subsidiary of Lantern Pharma Inc. (NASDAQ: LTRN), today announced that the U.S. Food and Drug Administration (FDA) has cleared its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results